Ayala Return on Sales from 2010 to 2024
| ADXSDelisted Stock | USD 0.62 0.03 4.62% |
Check Ayala Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ayala main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Ayala financial statements analysis is a perfect complement when working with Ayala Pharmaceuticals Valuation or Volatility modules.
Ayala |
About Ayala Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Ayala Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Ayala Pharmaceuticals investors use historical funamental indicators, such as Ayala Pharmaceuticals's Return on Sales, to determine how well the company is positioned to perform in the future. Although Ayala Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Ayala Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ayala Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ayala Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ayala Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes technology antigen delivery products in the United States. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey. Advaxis operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 14 people.
Pair Trading with Ayala Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ayala Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ayala Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Ayala OTC Stock
| 0.81 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
Moving against Ayala OTC Stock
| 0.78 | YS | YS Biopharma | PairCorr |
| 0.75 | VERU | Veru Inc Financial Report 9th of May 2024 | PairCorr |
| 0.67 | DOMH | Dominari Holdings | PairCorr |
| 0.61 | DNTH | Dianthus Therapeutics Symbol Change | PairCorr |
| 0.6 | VCEL | Vericel Corp Ord Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to Ayala Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ayala Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ayala Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ayala Pharmaceuticals to buy it.
The correlation of Ayala Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ayala Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ayala Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ayala Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Ayala OTC Stock
If you are still planning to invest in Ayala Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ayala Pharmaceuticals' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world |